Daphne A. Stanley
National Institutes of Health(US)National Institute of Allergy and Infectious Diseases(US)
Publications by Year
Research Areas
Viral Infections and Outbreaks Research, Viral Infections and Vectors, Hepatitis B Virus Studies, Virus-based gene therapy research, SARS-CoV-2 and COVID-19 Research
Most-Cited Works
- → Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody(2016)417 cited
- → A Recombinant Vesicular Stomatitis Virus Ebola Vaccine(2015)386 cited
- → A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA(2015)354 cited
- → Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge(2014)349 cited
- → Chimpanzee Adenovirus Vector Ebola Vaccine(2014)281 cited
- → CD8+ cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primates(2011)224 cited
- → Recombinant Adenovirus Serotype 26 (Ad26) and Ad35 Vaccine Vectors Bypass Immunity to Ad5 and Protect Nonhuman Primates against Ebolavirus Challenge(2011)221 cited
- → Use of ChAd3-EBO-Z Ebola virus vaccine in Malian and US adults, and boosting of Malian adults with MVA-BN-Filo: a phase 1, single-blind, randomised trial, a phase 1b, open-label and double-blind, dose-escalation trial, and a nested, randomised, double-blind, placebo-controlled trial(2015)214 cited
- → Demonstration of Cross-Protective Vaccine Immunity against an Emerging Pathogenic Ebolavirus Species(2010)139 cited
- → Safety and immunogenicity of Ebola virus and Marburg virus glycoprotein DNA vaccines assessed separately and concomitantly in healthy Ugandan adults: a phase 1b, randomised, double-blind, placebo-controlled clinical trial(2014)125 cited